Search
for
Sort by
Research 571–600 of 1000+
- Baricitinib Provides Higher Efficacy in Adolescents Relative to Adults With Alopecia Areata Despite More Severe Disease at Baseline: 36-Week Outcomes From BRAVE-AA Trials
- Long‐Term Real‐World Outcomes of Baricitinib in Severe Alopecia Areata: A 104‐Week Retrospective Analysis From a Single Institute
- Baricitinib-Induced Trichilemmal Cyst Reactivation in a Woman With Alopecia Areata
- Ponatinib-induced pityriasis rubra pilaris-like adnexal dysmaturation: A case report
- The Efficacy of Baricitinib as a Treatment Option for Alopecia, In Terms of Promoting Hair Regrowth and Improving Patient Reported Outcomes
- Efficient establishment of an optimized culture condition for cashmere goat primary hair follicle stem cells
- EE325 Budget Impact of Baricitinib for Patients with Severe Alopecia Areata
- <i>JAMA Dermatology—</i>The Year in Review, 2021
- Tofacitinib therapy for the treatment of alopecia areata: Report of 11 patients
- 873 The effect of Cilostazol on hair growth: A novel therapeutic option for the treatment of hair loss
- Alisertib is active as single agent in recurrent atypical teratoid rhabdoid tumors in 4 children
- Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy
- CDK4/6 plus aromatase inhibitor-induced alopecia in breast cancer patients.
- Valproic Acid Induces Hair Regeneration in Murine Model and Activates Alkaline Phosphatase Activity in Human Dermal Papilla Cells
- The Role of Tofacitinib in the Management of Alopecia Totalis
- GSK-3 Inhibitors: Recent Developments and Therapeutic Potential
- Effectiveness of Baricitinib on Nail Alopecia Areata: A 48-Week Single-Center Retrospective Study
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- Hair regrowth in a patient with alopecia universalis and psoriasis vulgaris during deucravacitinib therapy
- S116 Treatment of Concomitant Alopecia Areata and Crohn’s Disease in a Young Child With Tofacitinib: Case Report
- Upadacitinib for the treatment of alopecia areata and severe atopic dermatitis in a paediatric patient: A case report
- Treatment of discoid lupus erythematosus scarring alopecia with deucravacitinib: A case report
- Anti-Acne Agents Attenuate FGFR2 Signal Transduction in Acne
- Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial
- Nilotinib-Induced Keratosis Pilaris
- Factors regulating quiescent stem cells: insights from the intestine and other self-renewing tissues
- Moving Beyond Boundaries: Utilization of Longitudinal Exposure–Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development Paradigm
- Understanding The Molecular Mechanisms Of Hair Follicle Stem Cell Quiescence And Genome Plasticity
- Single-cell transcriptomics reveals hair growth retardation mediated by aberrant connective tissue sheath contraction in male androgenetic alopecia
- Efficacy and safety of ritlecitinib in adolescents with alopecia areata: Results from the ALLEGRO phase 2b/3 randomized, double‐blind, placebo‐controlled trial